Assembly Biosciences, Inc. (ASMB) Social Stream

Featured Post From StockTwits About ASMB

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend.

$ASMB
Market Price - $3.59
Average Hold - $4.38
Accumulate - Sub $3.25
Price Target - $6.25
Estimated Time Hold - 2Q
Support - $4, $7
Floor - $3.33
Double Down Target - Sub $3.25
Option - N/A
Micro DD - We are also encouraged by the enhanced profile of our fourth core inhibitor, which we plan to nominate by mid-year and has potential to be best-in-class, said John McHutchison, AO, MD, Chief Executive Officer and President of Assembly Bio. “The further analyses from the Phase 2 studies of VBR in our EASL poster presentations continue to inform our development strategy and the HBV field and will provide us greater insight as we conduct clinical trials combining our core inhibitors with NrtI and additional antiviral mechanisms. Overall, our data to date support our belief that core inhibitors combined with NrtI will form the backbone of finite and curative therapies for patients.”